Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. EBITDA margin (%)

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 20256.8+28.82%
Mar 31, 20245.3-22.08%
Mar 31, 20236.7-9.27%
Mar 31, 20227.4-20.26%
Mar 31, 20219.3-0.23%
Mar 31, 20209.3+20.42%
Mar 31, 20197.8+20.78%
Mar 31, 20186.4-12.43%
Mar 31, 20177.3+2.83%
Mar 31, 20167.1+36.33%
Mar 31, 20155.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)